<?xml version="1.0" encoding="UTF-8"?>
<ref id="B135-pharmaceuticals-12-00060">
 <label>135.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bernatchez</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Coste</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Beck</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Luna</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Sohl</surname>
    <given-names>C.D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2018</year>
  <volume>62</volume>
  <fpage>e00725-18</fpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00725-18</pub-id>
  <?supplied-pmid 30061280?>
  <pub-id pub-id-type="pmid">30061280</pub-id>
 </element-citation>
</ref>
